HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Dicarbine

HCID 65684
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
17411-19-7
Standard SMILES
Cc1ccc2c(c1)C1CN(C)CCC1N2
InChIKey
CYJQCYXRNNCURD-UHFFFAOYSA-N
Molecular formula
C13H18N2
Average molar mass
202.3 g/mol
Monoisotopic mass
202.14699858

Overview

minor descriptor (77-84); on-line & Index Medicus search CARBOLINES (77-84); RN given refers to parent cpd without isomeric designation

Names & identifiers

Preferred name
Dicarbine
IUPAC
2,8-dimethyl-1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indole
English name
Dicarbine
Molecular formula
C13H18N2
Molecular weight
202.3

Names & synonyms

Dicarbine17411-19-7DicarbinaDicarbinumDTXSID0046193Y0EA50IJ3V2,3,4,4a,5,9b-Hexahydro-2,8-dimethyl-1H-pyrido(4,3-b)indoleDTXCID80261931H-Pyrido(4,3-b)indole, 2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-2,3,4,4a,5,9b-Hexahydro-2,8-dimethyl-1H-pyrido[4,3-b]indole1H-Pyrido[4,3-b]indole, 2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-RefChem:132989
Show more names
DP 101312,8-Dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoleDicarbine [INN]2,8-dimethyl-1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indoleDicarbinum [INN-Latin]Dicarbina [INN-Spanish]F1176-0001251646-41-0

Database identifiers

CAS
17411-19-7、75494-88-1
PubChem CID
65684
DTXSID
DTXSID0046193
ChEMBL
CHEMBL2106105、CHEMBL418675
UNII
Y0EA50IJ3V
EC Number
675-489-2、963-322-9
Nikkaji
J9.100F

Properties

Computed structural properties

XLogP
2.3
Topological polar surface area
15.3 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
0
Heavy atoms
15
Formal charge
0
Complexity
241

Physicochemical properties

Boiling point
305.7 · 305.7±42.0 °C(Predicted)
Density
1.043 · 1.043±0.06 g/cm3(Predicted)
pka
9.58 · 9.58±0.20(Predicted)
FDA UNII
0 EA50IJ3V · Y0EA50IJ3V
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H335-H319
Precautionary statements
264 · P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

Hazard information

Hazard Classes and Categories · 2 items

Skin Irrit. 2 (100%)

Acute Tox. 4 (100%)

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H315-H335-H319
Precautionary statements
P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 5 items

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.

An agent that causes the production of physical defects in the developing embryo.

Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.

Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved.

Applications

UsesPharmaceutic aid (plasticizer).

Suppliers12 total

成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
上海皓鸿生物医药科技有限公司400-8210725 4008210725 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]

Related reactions

3 records
New reaction record
HRID 1400515 reaction equation
HRID 1400515As reactantuspto-grants-2014_12
HRID 1401588 reaction equation
HRID 1401588As reactantuspto-grants-2014_12
HRID 1773277 reaction equation
HRID 1773277As reactantuspto-grants-2016_02

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
BOC Sciences16314854226; +8616314854226 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]
上海安米克化学品有限公司微信 18019252918 18019252918 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
Alchem Pharmtech,Inc.8485655694 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
合肥钼凯医药科技有限公司18001872185; 18001872185 · [email protected]